Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Shockwave Medical Inc (NQ: SWAV )

280.38 +5.29 (+1.92%)
Streaming Delayed Price Updated: 1:53 PM EDT, Jun 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Shockwave Medical Inc

Shockwave Medical Publishes 2022 ESG Report
From Shockwave Medical, Inc.
Via GlobeNewswire
Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Big pharma stocks Novartis, Eli Lilly, Merck, and Novo Nordisk are outperforming the market, driven by successful drugs and strong earnings growth. 
Via MarketBeat
Topics Economy
Exposures Economy
Shockwave Appoints Kevin Ballinger to Board of Directors
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical, Fast Grower, In Boston Scientific's Sights?
Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave. 
Via MarketBeat
Topics ETFs
Shockwave Medical Inc. (NASDAQ: SWAV) is a Leading Gainer in Friday Morning Trading
Via Investor Brand Network
Shockwave Medical Launches New Coronary IVL Catheter Internationally and Enrolls First Patient in All-Female Empower Study
From Shockwave Medical, Inc.
Via GlobeNewswire
Are Small Caps a Harbinger of Market Declines?
The iShares Russell 2000 ETF outperformed the S&P 500 last week, but that may be short-lived. Small-cap momentum is often a bellwether for broad-market action. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
Shockwave Medical Reports First Quarter 2023 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2023 Results and Participation in Upcoming Investor Conference
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Gets 10% Jolt, Leads Medical Gear Makers Higher
Shockwave got a 10.64% jolt on a proposed Medicare change that could up the usage of its gear. Other medical product makers are forming bullish consolidations. 
Via MarketBeat
Shockwave Medical Completes Acquisition of Neovasc
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Exposures Product Safety
Shockwave Medical Completes Acquisition of Neovasc
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Announces U.S. Launch of New Peripheral IVL Catheter
Shockwave L⁶ Provides Physicians with Larger-Diameter Catheters to Expand Potential Treatment of Peripheral Vessels 
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
3 Mid-Cap Earnings Plays to Watch This Week
Mid-caps could continue to be the hot hand for traders and investors alike. Keep an eye on these three upcoming earnings reports. 
Via MarketBeat
Topics Economy
Exposures Economy
Updated SCAI Guidance Includes Coronary IVL as a Treatment Option in All U.S. Catheterization Labs Regardless of Surgical Backup Status
Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not Recommended 
From Shockwave Medical, Inc.
Via GlobeNewswire
Mergers and Acquisitions in 2023 Off To A Strong Start
Mergers and acquisitions are common, especially across the health sector. Here are some lesser-known buyouts and how they could fare down the road. 
Via MarketBeat
Exposures Product Safety
Neovasc (NASDAQ: NVCN) (TSX: NVCN) Enters into Agreement to be Acquired by Shockwave Medical (NASDAQ: SWAV) for $100 Million & CVR
Neovasc, Inc. (NASDAQ: NVCN) (TSX: NVCN) is engaged as a specialty medical device company, which is focused on the development, 
Via Spotlight Growth
Exposures Product Safety
Shockwave Medical Announces Agreement to Acquire Neovasc
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Provides Quarterly Earnings Release Dates for 2023
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical to Participate in the Piper Sandler 34th Annual Healthcare Conference
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Publishes Inaugural ESG Report
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Reports Third Quarter 2022 Financial Results
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Confirms Consistent Outcomes for IVL in the Largest Prospective “Real World” Study of Patients with Heavily Calcified Peripheral Arterial Disease
Disrupt PAD III Observational Study Results Confirm Safety and Effectiveness of IVL in Patients with Complex Calcified Lesions 
From Shockwave Medical, Inc.
Via GlobeNewswire
Shockwave Medical Announces Details for Conference Call Discussing Third Quarter 2022 Results
From Shockwave Medical, Inc.
Via GlobeNewswire
ShockWave Stuns With 40% Post-Earnings Price Move: Is It A Buy?
Shockwave Medical bolted 40% higher since its second-quarter earnings report on August 8. It's currently trading at new highs, but is it the right time to buy? 
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.